Cargando…

435. Outcomes for E484K Mutation Negative COVID-19 Patients Cohorted with E484K Mutation Positive COVID-19 Patients: A Retrospective Cohort Study

BACKGROUND: The emergence of the E484K mutation of SARS-CoV-2 poses a risk of immune evasion but the risk of re-infection during acute infection is not well defined. Our aim was to assess the risk of re-infection among patients with existing acute E484K mutation negative COVID-19 infection who were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buskandar, Fahad, Linkneheld-Struk, Amber L, Williams, Victoria R, Chan, Adrienne, Mieusement, Lorraine Maze Dit, Salt, Natasha, Leis, Jerome A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644981/ http://dx.doi.org/10.1093/ofid/ofab466.634

Ejemplares similares

E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil
por: Ferrareze, Patrícia Aline Gröhs, et al.
Publicado: (2021)

794. The Role of the Environment in Healthcare-associated Transmission of Vancomycin Resistant Enterococcus: A Proof of Concept Study
por: Linkneheld-Struk, Amber L, et al.
Publicado: (2021)

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
por: Jangra, Sonia, et al.
Publicado: (2021)

Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
por: Nonaka, Carolina K. V., et al.
Publicado: (2021)

Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany
por: Jensen, Bjoern, et al.
Publicado: (2021)

CRISPR-Cas12a-Based Detection of SARS-CoV-2 Harboring the E484K Mutation
por: Marqués, María-Carmen, et al.
Publicado: (2021)

SARS-CoV-2 E484K Mutation Narrative Review: Epidemiology, Immune Escape, Clinical Implications, and Future Considerations
por: Yang, Wan-Ting, et al.
Publicado: (2022)

Rapid and accurate identification of SARS-CoV-2 variants containing E484 mutation
por: Zhang, Yuan, et al.
Publicado: (2021)

Identification of E484K and other novel SARS-COV-2 variants from the Kingdom of Bahrain
por: Bindayna, Khalid Mubarak, et al.
Publicado: (2021)

A novel diagnostic test to screen SARS-CoV-2 variants containing E484K and N501Y mutations
por: Zhao, Yanan, et al.
Publicado: (2021)

De novo emergence of the mutation E484K in a SARS-CoV-2 B.1.1.7 lineage variant()
por: Urrutikoetxea-Gutierrez, Mikel, et al.
Publicado: (2022)

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
por: Cherian, Sarah, et al.
Publicado: (2021)

Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron
por: Schröder, Simon, et al.
Publicado: (2023)

Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy
por: Baj, Andreina, et al.
Publicado: (2021)

Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals
por: Uwamino, Yoshifumi, et al.
Publicado: (2022)

RPA-ligation-qPCR combined method for genotyping the SARS-CoV-2 key mutation E484Q: Genotyping SARS-CoV-2 E484Q by RPA-ligation-qPCR
por: Wang, Pei, et al.
Publicado: (2022)

Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France
por: Colson, Philippe, et al.
Publicado: (2022)

Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K
por: Laiton-Donato, Katherine, et al.
Publicado: (2021)

Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates
por: Moustafa, Ahmed M, et al.
Publicado: (2021)

A discernable increase in the severe acute respiratory syndrome coronavirus 2 R.1 lineage carrying an E484K spike protein mutation in Japan
por: Sekizuka, Tsuyoshi, et al.
Publicado: (2021)

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
por: Jangra, Sonia, et al.
Publicado: (2021)

Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan
por: Hirotsu, Yosuke, et al.
Publicado: (2021)

Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2
por: Zhang, Zhikai, et al.
Publicado: (2022)

Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA
por: Skidmore, Peter T., et al.
Publicado: (2021)

Risk of SARS-CoV-2 transmission from universally masked healthcare workers to patients or residents: A prospective cohort study
por: Williams, Victoria R., et al.
Publicado: (2021)

POS-484 COVID-19 RISK PERCEPTION IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE
por: Joslin, J., et al.
Publicado: (2021)

Conjunctival Swab Findings in 484 COVID-19 Patients in Four Hospital Centers in Slovakia
por: Furdova, Alena, et al.
Publicado: (2022)

Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2021)

Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 isolates from Pennsylvania
por: Moustafa, Ahmed M., et al.
Publicado: (2021)

Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study
por: Zhao, Shi, et al.
Publicado: (2021)

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
por: Ferreira, Isabella A T M, et al.
Publicado: (2021)

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage
por: Álvarez-Díaz, Diego A., et al.
Publicado: (2022)

Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK
por: Toovey, Oliver T.R., et al.
Publicado: (2021)

484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
por: Skinner, Murray, et al.
Publicado: (2012)

MON-484 Thyroid Nodules: Not so Simple to Manage
por: Cruz, Alegyari Figueroa, et al.
Publicado: (2020)

Emergence of OXA-484-Producing Klebsiella variicola in China
por: Ge, Haoyu, et al.
Publicado: (2023)

Emergence and onward transmission of a SARS-CoV-2 E484K variant among household contacts of a bamlanivimab-treated patient
por: Sabin, Arick P., et al.
Publicado: (2022)

Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère
por: Peiffer-Smadja, N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1rjggq2beahquia5o96teo1eag